Health Affairs, 28, no. 5 (2009): w969-w977
(Published online 25 August 2009)
doi: 10.1377/hlthaff.28.5.w969
© 2009 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Comments: View responses
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Google Scholar
* Articles by Light, D. W.
PubMed
* PubMed Citation
* Articles by Light, D. W.
Related Collections
* International Issues
* Business Of Health
* Pharmaceuticals
* Research And Technology
*Related Articles

Web Exclusives

Global Drug Discovery: Europe Is Ahead

Donald W. Light

It is widely believed that the United States has eclipsed Europe in pharmaceutical research productivity. Some leading analysts claim that although fewer drugs have been discovered worldwide over the past decade, most are therapeutically important. Yet a comprehensive data set of all new chemical entities approved between 1982 and 2003 shows that the United States never overtook Europe in research productivity, and that Europe in fact is pulling ahead of U.S. productivity. Other large studies show that most new drugs add few if any clinical benefits over previously discovered drugs. I discuss ways in which Congress, employers, and insurers can increase the value of drugs and revitalize the U.S. pharmaceutical industry.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?

Related Articles

  • Tahir Amin, Rahul Rajkumar, Priti Radhakrishnan, and Aaron S. Kesselheim
    Expert Review Of Drug Patent Applications: Improving Health In The Developing World
    Health Affairs, September/October 2009; 28(5): w948-w956.
    [Abstract] [Full Text] [PDF] [Table Of Contents]
     
  • Ellen R. Shaffer and Joseph E. Brenner
    A Trade Agreement’s Impact On Access To Generic Drugs
    Health Affairs, September/October 2009; 28(5): w957-w968.
    [Abstract] [Full Text] [PDF] [Appendix]
     


Comments:

Read all Comments

Global Drug Discovery Report Paints Misleading Picture
Ken Johnson
Health Affairs, 26 Aug 2009 [Full text]
Global Drug Discovery: Comparing Apples To Apples
Jerry Norris
Health Affairs, 26 Aug 2009 [Full text]
Questionable Assessment Of R&D Productivity
Yann Gaston-Mathé
Health Affairs, 27 Aug 2009 [Full text]
Light Paints Distored Picture of U.S. Pharmaceutical R&D Efforts
Lori M. Reilly, et al.
Health Affairs, 25 Sep 2009 [Full text]